BartterSite.org Home | Back to List of Magnesium Articles
American Journal of Clinical Nutrition, Vol. 69, No. 1, 70-73, January 1999
© 1999 American Society for Clinical Nutrition
Original Research Communications |
ABSTRACT |
---|
TOP ABSTRACT INTRODUCTION SUBJECTS AND METHODS RESULTS DISCUSSION REFERENCES |
---|
Objective: The present study evaluated the serum and urinary magnesium concentrations in groups of young diabetic subjects in Bangladesh.
Design: Forty patients newly diagnosed with diabetes [13 with fibrocalculus pancreatic diabetes (FCPD), 13 with protein-deficient diabetes (PDDM), and 14 with type 2 diabetes mellitus] were studied along with 13 healthy control and 13 malnourished control subjects [body mass index (in kg/m2) <19]. Magnesium was measured by atomic absorption spectrophotometry.
Results: Malnutrition itself was not related to the serum glucose (fasting: 3.68 ± 0.74 and 4.11 ± 0.29 mmol/L; postprandial: 6.30 ± 0.41 and 6.00 ± 0.24 mmol/L for healthy and malnourished control subjects, respectively) or serum or urinary magnesium (serum: 0.73 ± 0.03 and 0.75 ± 0.05 mmol/L; urinary: 232 ± 124 and 243 ± 88 mmol Mg/mol creatinine for healthy and malnourished control subjects, respectively) concentration. Subjects with FCPD and PDDM had significantly lower serum magnesium concentrations (PDDM: 0.68 ± 0.06 mmol/L, FCPD: 0.66 ± 0.07 mmol/L) than those in both control groups. In contrast with 0% of healthy and 7.7% of malnourished control subjects, 42.85% of type 2 diabetic subjects, 61.54% of those with PDDM, and 69.23% of those with FCPD were hypomagnesemic. Subjects with FCPD and PDDM had significantly higher urinary excretion of magnesium than the healthy and malnourished control subjects and the type 2 diabetic subjects. Hypermagnesuria paralleled hypomagnesemia.
Conclusions: Malnutrition may not itself give rise to glucose intolerance, and serum magnesium deficiency seems to be a consequence rather than a cause of diabetes mellitus.
Key Words: Diabetes mellitus • malnutrition • malnutrition-related diabetes mellitus • FCPD • protein-deficient diabetes mellitus • PDDM • glucose intolerance • magnesium • fibrocalculus pancreatic diabetes • young adults
INTRODUCTION |
---|
TOP ABSTRACT INTRODUCTION SUBJECTS AND METHODS RESULTS DISCUSSION REFERENCES |
---|
A substantial number of diabetic subjects in tropical, developing countries are young, nonketotic, and suffer from a type of diabetes termed "malnutrition-related diabetes mellitus" (MRDM) by the WHO Study Group on Diabetes Mellitus (10). MRDM is further subclassified into fibrocalculus pancreatic diabetes (FCPD) and protein-deficient diabetes mellitus (PDDM). About 55% (42% for PDDM and 13% for FCPD) of the diabetic patients in Bangladesh <30 y of age have MRDM (11). Although some clinical and biochemical peculiarities of these subjects have been recognized (12–15), the etiopathology of MRDM is still unclear. Even the role of malnutrition in this disease is disputed (16).
In light of the evidence of magnesium imbalance in diabetes mellitus, it is important to study magnesium metabolism in MRDM, which may be associated with malnutrition and consequent hypomagnesemia. No report has yet been published on the serum magnesium concentrations of subjects with MRDM. Moreover, no study has yet reported the serum and urinary magnesium concentrations of either the normal or diabetic population of Bangladesh. The objective of the present study was to investigate the serum and urinary magnesium status of early-onset diabetic subjects in Bangladesh with particular reference to MRDM patients.
SUBJECTS AND METHODS |
---|
TOP ABSTRACT INTRODUCTION SUBJECTS AND METHODS RESULTS DISCUSSION REFERENCES |
---|
Twenty-six age- and sex-matched subjects of similar socioeconomic backgrounds with no family history of diabetes up to the second generation served as controls. Of the 26 control subjects selected, 13 (4 female, 9 male) with BMIs 19 served as healthy control subjects and 13 (5 female, 8 male) with BMIs <19 served as malnourished control subjects (10).
Diabetic persons with ketosis, microvascular complications, hypertension, or any other chronic diseases revealed by routine clinical and biochemical examinations were excluded from the study. Pregnant women were also excluded. None of the study subjects had taken any vitamin or mineral supplements in the recent past.
Collection of samples
Serum from overnight (12 h) fasting and a postprandial venous blood sample (2 h after a 75-g oral glucose load) were separated by centrifugation (1300 x g for 10 min) within 30 min after collection into capped, airtight polyethylene test tubes and were preserved at -40°C for estimation of serum magnesium and other biochemical measures. After overnight urine was discarded, fasting urine samples were collected and preserved at -40°C for estimation of urinary magnesium. All laboratory wares were washed properly beforehand by following a standardized procedure (17). All laboratory reagents used for determination of magnesium were prepared with distilled, deionized water.
Biochemical methods
Serum glucose was measured by using the glucose-oxidase method (Boehringer-Mannheim, Mannheim, Germany) method. Serum and urinary magnesium concentrations were estimated by atomic absorption spectrophotometry (model AA-680; Shimadzu, Tokyo) using an air-acetylene flame with a single hollow cathode lamp. Appropriate dilutions of both serum and urine samples were prepared by adding deionized water. Standard reference materials (Seronorm, trace elements, serum; Nycomed Pharma AS, Oslo) were analyzed for each batch to check the accuracy of the method. The reproducibility of the method was verified by analyzing 10 identical samples; the CV was 2.21% for magnesium.
Statistical methods
The differences between groups were analyzed by using analysis of variance (Duncan's new multiple-range test, significance set at P < 0.05) and the proportion test when applicable. Analysis of variance was calculated by using the SPSS package for Windows (SPSS Inc, Chicago).
RESULTS |
---|
TOP ABSTRACT INTRODUCTION SUBJECTS AND METHODS RESULTS DISCUSSION REFERENCES |
---|
|
|
|
DISCUSSION |
---|
TOP ABSTRACT INTRODUCTION SUBJECTS AND METHODS RESULTS DISCUSSION REFERENCES |
---|
The current data also suggest that serum magnesium concentrations remain unchanged even in the face of weight loss in nondiabetic subjects. The finding of a highly significant reduction of serum magnesium in diabetic patients with similar BMIs (subjects with FCPD and PDDM) leads to the conclusion that serum magnesium deficiency is a consequence rather than a cause of diabetes in these patients. The conclusion is further substantiated by the fact that a significantly larger proportion of diabetic patients with much higher BMIs (type 2 diabetic group) showed significant hypomagnesemia.
The pathophysiologic mechanism of hypomagnesemia in diabetes mellitus has remained controversial, particularly the relative roles of hyperglycemia and insulin resistance (1, 2, 19–21). It may be difficult to show the relation between hyperglycemia and serum magnesium at a limited range of hyperglycemia. The present study had 2 groups of patients (those with FCPD and PDDM) with considerable hyperglycemia without ketosis and, thus, provided us with a unique opportunity to explore the relation between serum glucose and magnesium and also between serum glucose and urinary magnesium. Although serum magnesium and glucose concentrations (fasting and postprandial) did not show any significant correlation, the close parallelism between percentage of hypomagnesemic and hypermagnesuric cases in the various groups suggests a major role of hyperglycemia in the development of hypomagnesemia as a result of increased magnesium excretion. Detailed study with more reliable markers of glycemic status, such as glycated hemoglobin, may help to reveal the relation of serum magnesium to glucose concentrations in these subjects.
We gratefully acknowledge the financial support of the Bangladesh Medical Research Council and the International Program in the Chemical Sciences, Uppsala University, Sweden.
FOOTNOTES |
---|
2 Supported by the Bangladesh Medical Research Council, Dhaka, and the International Program in the Chemical Sciences, Uppsala University, Sweden.
3 Address reprint requests to L Ali, Research Division, BIRDEM, 122, Kazi Nazrul Islam Avenue, Dhaka-1000, Bangladesh. E-mail: lali@citechco.net .
REFERENCES |
---|
TOP ABSTRACT INTRODUCTION SUBJECTS AND METHODS RESULTS DISCUSSION REFERENCES |
---|